Doctors in today’s world are fully capable of managing cancer, the main issue is keeping doctors up to date with the correct data. Whether it is modernizing treatment options or keeping up to speed on patient records, the medical industry would flourish if the exchange of data had become more efficient.Eric Lefkofsky is the founder of Tempus, the ultimate database solution that will keep medical professionals in touch with the modern perspective of cancer treatments. Patient data may be combined within their system to determine genetic predisposition to cancer formation.Clinical data is highly valuable, but the truth about our knowledge about cancer will not come out without content data from the patient response. The medical industry is still purely based on theoretics and positive speculation at best. Eric’s theory is that patients may have different responses to treatments based on their genetics. Billions of dollars in chemotherapy and other reactionary treatments are going to waste for some people.
Herceptin is the most common medication that is initially used for breast cancer patients. The issue is that it only works for 40% of women and the research team is still clueless as for why it has that success rate. Other health factors may come into play, but the medical industry rarely takes note of the seemingly subtle details.Eric Lefkofsky is a well-rounded entrepreneur with a deep background in the technology industry. He is the co-founder of one of the biggest e-commerce marketplaces, Groupon. He is also the founder of the venture capital firm Lightbank. With all of his ventures, he now has a net worth of nearly $2 billion.
Eric is also running multiple charitable organizations. The Lefkofsky Foundation branches out into multiple fields including education, medical research, cultural enrichment and more. The organization is run by both him and his wife. They are also active contributors to The Giving Pledge. TGP is an organization made up of millionaires and billions that have signed agreements to give the majority of their wealth to select charitable organizations. Eric is just a tiny fraction of the cause since the entire fund is worth $365 billion.